510(k) K130470
K130470 is an FDA 510(k) premarket notification submitted by Geneohm Sciences Canada, Inc. (Bd Diagnostics) for the device "BD MAX CDIFF ASSAY, BD MAX INSTRUMENT". The FDA issued a decision of Substantially Equivalent on Apr 2, 2013. The device falls under product code OZN (C. Difficile Toxin Gene Amplification Assay), a Class II device regulated under 21 CFR 866.3130. Geneohm Sciences Canada, Inc. (Bd Diagnostics) has 3 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 2, 2013
- Date Received
- Feb 25, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- C. Difficile Toxin Gene Amplification Assay
- Device Class
- Class II
- Regulation Number
- 866.3130
- Review Panel
- MI
- Submission Type
- 510(k)
Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.
Need the full FDA record for Geneohm Sciences Canada, Inc. (Bd Diagnostics)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.